Abstract
In normal rats treated with 1,25(OH)2D3 or 24,25(OH)2D3, serum Ca2+, ALP, PRL and GH are significantly altered. In order to study the primary effect of vitamin D3 analogues on target organ function, rat UMR 106 osteosarcoma and GH3 pituitary adenoma cells in monolayer culture were exposed accordingly.
Surprisingly, prolonged exposure of these cell lines to physiological levels of either 1,25(OH)2D3 or 24,25(OH)2D3 did not significantly affect the secretory parameters (ALP, PRL or GH) tested. However, 1,25(OH)2D3 exposure significantly reduced PTH- and Gpp(NH)p-elicited AC as well as Gpp(NH)p-stimulated PLC activities in the UMR 106 cells. These changes were accompanied by an increase and decrease in the membrane contents of the G-protein subunits G36β and Gq/11α, respectively. In contrast, 24,25(OH)2D3 remained without significant biological effect on these signalling systems despite concomitantly augmented levels of G36β. TRH- and Gpp(NH)p-elicited PLC activities in the GH3 cells were significantly reduced by 1,25(OH)2D3 with a concurrent reduction in cellular amounts of Gq/11α, however, 24,25(OH)2D3 did not significantly alter any signalling systems nor G-proteins analyzed.
It is concluded that the osteoblastic and pituitary cell secretion of ALP, PRL and GH remain unaffected by the presence of 1,25(OH)2D3 and 24,25(OH)2D3, despite distinct alterations in components of G-protein mediated signalling pathways. Hence, other factors like ambient Ca2+ may be responsible for the perturbed secretory patterns of ALP and PRL seen in vitamin D3 treated rats.
Similar content being viewed by others
Abbreviations
- AC:
-
adenylate cyclase
- ALP:
-
alkaline phosphatase
- BGP:
-
osteocalcin
- BSA:
-
bovine serum albumin
- DA:
-
dopamine
- DAG:
-
diacylglycerol
- GH:
-
growth hormone
- GHRH:
-
growth hormone releasing hormone
- Gpp(NH)p:
-
guanosine 5′-[βγ-imido]triphosphate
- G-protein:
-
guanine nucleotide-binding regulatory protein
- Gsα etc.:
-
Gs protein α-subunit
- IP3 :
-
inositol 1,4,5 trisphosphate
- OAF:
-
osteoclast activating factor
- PGE2 :
-
prostaglandin E2
- PKA & PKC:
-
protein kinase A & C
- PLC:
-
phospholipase C
- PRL:
-
prolactin
- PTH:
-
parathyroid hormone
- SRIF:
-
somatostatin
- TRH:
-
thyrotropin releasing hormone
- VIP:
-
vasoactive intestinal peptide
- 25(OH)D3 :
-
25 hydroxy vitamin D3
- 1,25(OH)2D3 :
-
1·25 dihydroxy vitamin D3
- 24,25(OH)2D3 :
-
24,25 dihydroxy vitamin D3
References
Ben-Jonathan, N. (1985) Dopamine: A prolactin inhibiting hormone.Endocr. Rev. 6:564–589.
Bernstein, S. H., Kharbanda, S. M., Sherman, M. L., Stone, R. M. and Kufe, D. W. (1991) Inhibition of protein kinase C is associated with a decrease inc-myc expression in human myeloid leukemia cells.FEBS Lett. 294:73–76.
Bjøro, T., Sand, O., østberg, B. C., Gordeladze, J. O., Torjesen, P., Gautvik, K. M. and Haug, E. (1990) The mechanisms by which vasoactive intestinal peptide (VIP) and thyrotropin releasing hormone (TRH) stimulate prolactin release from pituitary cells.Biosci. Rep. 10:189–199.
Bjøro, T., Wiik, P., Opstad, P. K., Gautvik, K. M. and Haug, E. (1987) Binding and degradation of vasoactive intestinal peptide in prolactin-producing tumour cells (GH4C1).Acta Physiol. Scand. 130:609–618.
Bouillon, R. (1991) Growth hormone and bone.Horm. Res. 36 (suppl 1):49–55.
Caccavelli, L., Cussac, D., Pellegrini, I., Audinot, V., Jaquet, P. and Enjalbert, A. (1992) D2 dopaminergic receptors: normal and abnormal transduction mechanism.Horm. Res. 38:78–83.
Catherwood, B. D. (1985) 1,25-Dihydroxycholecalciferol and glucocortico-steroid regulation of adenylate cyclase in an osteoblast-like cell line.J. Biol. Chem. 260:736–743.
Charles, P., Hasling, C., Risteli, L., Risteli, J., Mosekilde, L. and Eriksen, E. F. (1992) Assessment of bone formation by biochemical markers in metabolic disease: separation between osteoblastic activity at the cell and tissue level.Calcif. Tissue Int. 51:406–411.
Civitelli, R., Reid, I. R., Westbrook, S., Avioli, L. V. and Hruska, K. A. (1988) Parathyroid hormone elevates inositol polyphosphates and diacylglycerol in a rat osteoblast-like cell line.Am. J. Physiol. 255:E660-E667.
DeLuca, H. F. and Schnoes, H. K. (1979) Recent developments in the metabolism of vitamin D. Vitamin D: basic research and its clinical application. In:Vitamin D: basic research and its clinical application. (Norman, A. W., Schaefer, K., von Herrath, D., Grigoleit, H. -G., Coburn, J. W., DeLuca, H. F., Mawer, E. B. and Suda, T., eds.) Berlin, Walter de Gruyter, pp. 445–458.
Epstein, S. (1988) Serum and urinary markers of bone remodeling: assessment of bone turnover.Endocr. Rev. 9:437–449.
Fiore, C. E., Clementi, G., Prato, A., Foti, R. and Conforto, G. (1988) Bone mineral content of the hyperprolactinemic rat femur by single photon absorptiometry.Horm. Metab. Res. 20:40–43.
Forrest, S. M., Ng, K. W., Findlay, D. M., Michelangeli, V. P., Livesey, S. A., Partridge, N. C., Zajac, J. D. and Martin, T. J. (1985) Characterization of an osteoblast-like clonal cell line which responds to both parathyroid hormone and calcitonin.Calcif. Tissue Int. 37:51–56.
Fujimori, A., Cheng, S. -L., Avioli, L. V. and Civitelli, R. (1992) Structure-function relationship of parathyroid hormone: activation of phospholipase-C, protein kinase-A and -C in osteosarcoma cells.Endocrinology 130:29–36.
Gautvik, K. M., Bjøro, T., Sletholt, K., Østberg, B. C., Sand, O., Torjesen, P., Gordeladze, J. O., Iversen, J. -G. and Haug, E. (1988) Regulation of prolactin secretion and synthesis by peptide hormones in cultured rat pituitary cells. In:Molecular mechanisms in secretion. Alfred Benzon Symposium 25. (Thorn, N. A., Treiman, M. and Pedersen, O. H., eds.) Copenhagen, Munksgaard, pp. 211–227.
Gautvik, K. M. and Lystad, E. (1981) Demonstration of heterogeneous population of binding sites for thyroliberin in prolactin producing tumour cells and their possible functional significance.Eur. J. Biochem. 116:235–242.
Gordeladze, J. O. and Gautvik, K. M. (1988) Hydroxycholecalciferols modulate parathyroid hormone and calcitonin sensitive adenylate cyclase in bone and kidney of rats. A possible physiological role for 24,25-dihydroxy vitamin D3.Biochem. Pharmacol. 35:899–902.
Gordeladze, J. O., Mortensen, B., Nordal, K., Halse, J., Dahl, E., Aksnes, L. and Gautvik, K. M. (1987) The effect of parathyroid hormone (PTH) and 24,25-dihydroxy-vitamin D3 on adenylyl cyclase of iliac crest biopsies: diagnostic and prognostic tool for evaluation and treatment of ureamic patients.Scand. J. Clin. Lab. Invest. 47 (suppl 186):13–20.
Haug, E. and Gautvik, K. M. (1976) Radioimmunoassay of rat prolactin and its use in measuring prolactin production by cultured pituitary cells.Acta Endocrinol. (Copenh) 82:282–297.
Haug, E. and Gautvik, K. M. (1978) Effects of sex steroids on growth hormone production in cultured rat pituitary cells.Acta Endocrinol. (Copenh) 87:40–54.
Haug, E., Pedersen, J. I. and Gautvik, K. M. (1982) Effects of vitamin D3 metabolites on production of prolactin and growth hormone in rat pituitary cells.Mol. Cell. Endocrinol. 28:65–79.
Herrmann-Erlee, M. P. M., van der Meer, J. M., Lowik, C. W. G. M., van Leeuwen, J. P. T. M. and Boonekamp, P. M. (1988) Different roles for calcium and cyclic AMP in the action of PTH: studies in bone expiants and isolated bone cells.Bone 9:93–100.
Hofstetter, W., Guenther, H. L., Stutzer, A., Schenk, R., Fleisch, H. and Friis, R. (1991) Establishment and characterization of two immortalized cell lines of the osteoblastic lineage.J. Bone Miner. Res. 6:609–622.
Ikeda, K., Imai, Y., Fukase, M. and Fujita, T. (1990) The effect of 1,25-dihydroxyvitamin D3 in human osteoblast-like osteosarcoma cell: modification of response to PTH.Biochem. Biophys. Res. Commun. 168:889–897.
Jablonski, G., Klem, K. H., Attramadal, A., Dahl, E., Rønningen, H., Gautvik, K. M., Haug, E. and Gordeladze, J. O. (1993) Surgically induced uraemia in rats. I: Effects on bone strength and metabolism.Biosci. Rep.,13:275–287.
Johnson, G. L. and Dhanasekaran, N. (1989) The G-protein family and their interaction with receptors.Endocr. Rev. 10:317–331.
Klein, R. F., Nissenson, R. A. and Strewler, G. J. (1991) Pertussis toxin inhibits hormonal stimulation of bone resorption in fetal rat limb bones.J. Pharmacol. Exp. Ther. 258:877–881.
Kleuss, C., Hescheler, J., Ewel, C., Rosenthal, W., Schultz, G. and Wittig, B. (1991) Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents.Nature 353:43–48.
Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4.Nature 227:680–685.
Leung, K. S., Fung, K. P., Sher, A. H., Li, C. K. and Lee, K. M. (1993) Plasma bone-specific alkaline phosphatase as an indicator of osteoblastic activity.J. Bone Joint Surg. 75:288–292.
McSheehy, P. M. J. and Chambers, T. J. (1986) Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone.Endocrinology 118:824–828.
McSheehy, P. M. J. and Chambers, T. J. (1987) 1,25 dihydroxyvitamin D3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption.J. Clin. Invest. 80:425–429.
Moriarty, T. M., Padrell, E., Carty, D. J., Omri, G., Landau, E. M. and Iyengar, R. (1990) G0 protein as signal transducer in the pertussis toxin-sensitive phosphatidylinositol pathway.Nature 343:79–82.
Mortensen, B., Gordeladze, J. O., Aksnes, L. and Gautvik, K. M. (1990) Long-term administration of vitamin D3 metabolites alters PTH-responsive osteoblastic adenylate cyclase in rats.Calcif. Tissue Int. 46:339–345.
Mortensen, B., Gordeladze, J. O., Haug, E., Schjerven, L. and Gautvik, K. M. (1993a) Relationship between circulating vitamin D3 metabolites and prolactin or growth hormone levels in rat.Pharmacol. Toxicol. 72:188–193.
Mortensen, B. M., Aarseth, H. P., Ganss, R., Haug, E., Gautvik, K. M. and Gordeladze, J. O. (1993b) 24,25-dihydroxyvitamin D3 treatment inhibits parathyroid-stimulated adenylate cyclase in iliac crest biopsies from uraemic patients.Bone 14:125–131.
Mortensen, B. M., Gautvik, K. M. and Gordeladze, J. O. (1993c) Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.Biosci. Rep. 13:27–39.
Mortensen, B. M., Gordeladze, J. O., Lyngdal, P. T., Aarseth, H. P. and Gautvik, K. M. (1993d) Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.Miner. Electrolyte Metab. 19:78–85.
Ng, K. W., Partridge, N. C., Niall, M. and Martin, T. J. (1983) Epidermal growth factor receptors in clonal lines of a rat osteogenic sarcoma and in osteoblast-rich rat bone cells.Calcif. Tissue Int. 35:298–303.
Partridge, N. C., Alcorn, D., Michelangeli, V. P., Ryan, G. and Martin, T. J. (1983) Morphological and biochemical characterization of four clonal osteogenic sarcoma cell lines of rat origin.Cancer Res. 43:4308–4314.
Partridge, N. C., Frampton, R. J., Eisman, J. A., Michelangeli, V. P., Elms, E., Bradley, T. R. and Martin, T. J. (1980) Receptors for 1,25(OH)2 vitamin D3 enriched in cloned osteoblast-like rat osteogenic sarcoma cells.FEBS Lett. 115:139–143.
Paulssen, E. J., Paulssen, R. H., Gautvik, K. M. and Gordeladze, J. O. (1992) Hypothalamic hormones modulates G protein levels and second messenger responsiveness in GH3 rat pituitary tumour cells.Biochem. Pharmacol. 44:471–477.
Paulssen, E. J., Paulssen, R. H., Haugen, T. B., Gautvik, K. M. and Gordeladze, J. O. (1991) Regulation of G protein mRNA levels by thyroliberin, vasoactive intestinal peptide and somatostatin in prolactin-producing rat pituitary adenoma cells.Acta Physiol. Scand. 143:195–201.
Payne, L. C., Obal, F. Jr., Opp, M. R., Krueger, J. M. (1992) Stimulation and inhibition of growth hormone secretion by interleukin-1β: the involvement of growth hormone-releasing hormone.Neuroendocrinology 56:118–123.
Pfeilschifter, J., Siegrist, E., Wuster, C., Blind, E. and Ziegler, R. (1992) Serum levels of intact parathyroid hormone and alkaline phosphatase correlate with cortical and trabecular bone loss in primary hyperparathyroidism.Acta Endocrinol. 127:319–323.
Pike, J. W., Parker, J. B., Haussler, M. R., Boass, A. and Toverud, S. U. (1979) Dynamic changes in circulating 1,25-dihydroxyvitamin D during reproduction in rats.Science 204:1427–1429.
Rasmussen, P. (1977) Calcium deficiency, pregnancy, and lactation in rats, some effects on blood chemistry and the skeleton.Calcif. Tissue Res. 23:87–94.
Reichlin, S. (1983) Somatostatin.N. Engl. J. Med. 309:1495–1501.
Schiltz, P. M., Ohta, T., Glass, D., Mohan, S. and Baylink, D. J. (1992) Growth hormone stimulates cortical bone formation in immature hypophysectomized rats.Endocr. Res. 18:19–30.
Shenker, A., Goldsmith, P., Unson, C. G. and Spiegel, A. M. (1991) The G protein coupled to tromboxane A2 receptor in human platelets is a member of the novel Gq family.J. Biol. Chem. 266:9309–9313.
Spiegel, A. M., Shenker, A. and Weinstein, L. S. (1992) Receptor-Effector Coupling by G Proteins: Implications for Normal and Abnormal Signal Transduction.Endocr. Rev. 13(3):536–565.
Strege, D. W., Kahn, A. J., Jeffrey, J. J., McGuire, M. M. and Partridge, N. C. (1990) Collagenase production by rat osteogenic sarcoma cells occurs in a discrete subpopulation of cells.Bone Mineral. 5:963–971.
Tashjian, A. H. Jr. (1979) Clonal strains of hormone producing pituitary cells.Methods Enzymol. 58:527–535.
Vargas, S. J., Feyen, J. H. M. and Raisz, L. G. (1989) Effects of pertussis toxin on resorption of 19-day-old fetal rat long bones.Endocrinology 124:2159–2165.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mortensen, B.M., Lund, H.W., Jablonski, G. et al. Direct effects of vitamin D3 analogues on G-protein mediated signalling systems in rat osteosarcoma cells and rat pituitary adenoma cells. Biosci Rep 15, 135–150 (1995). https://doi.org/10.1007/BF01207454
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01207454